Clinical impact of thymidine phosphorylase expression in gastric cancer

Oncology Reports

Volumn 10, Issue 3, 2003, Pages 561-566

  Noguchi, Tsuyoshi ^a   Fujiwara, Shozo ^a   Takeno, Shinsuke ^a   Kai, Shinya ^a   Mizuta, Akari ^a   Nagao, Yuko ^a   Uchida, Yuzo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; dThdPase; Fluorouracil; Gastric cancer; Prognosis

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELL DIFFERENTIATION; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; HUMAN; LYMPH NODE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE;

EID: 0642345167     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Takeno S, Noguchi T, Kikuchi R, Sato T, Uchida Y and Yokoyama S: Analysis of the survival period in resectable stage IV gastric cancer. Ann Surg Oncol 8: 215-221, 2001. (Pubitemid 32294801)
2. Takeno S, Noguchi T, Takahashi Y, Kikuchi R, Uchida Y and Yokoyama S: Immunohistochemical and clinicopathologic analysis of response to neoadjuvant therapy for esophageal squamous cell carcinoma. Dis Esophagus 14: 149-154, 2001. (Pubitemid 32951987)
3. Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y and Ishitsuka H: Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull 31: 175-178, 1983. (Pubitemid 13122231)
4. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okumura H, Yamada Y, Akiyama S and Aikou T: The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer 32: 1227-1232, 1996. (Pubitemid 26231808)
5. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K and Akiyama S: Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochimica Biophysica Acta 1034: 107-113, 1990. (Pubitemid 20114807)
6. Kobayashi N, Kubota T, Watanabe M, Otani Y, Teramoto T and Kitajima M: Pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase indicate chemosensitivity of human colon cancer specimens to doxifluridine and 5-fluorouracil, respectively. J Infect Chemother 5: 144-148, 1999. (Pubitemid 29484860)
7. Suzuki M, Usui N, Furugen Y and Mitsuhasi N: Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs. Int J Clin Oncol 6: 19-24, 2001. (Pubitemid 32230358)
8. Osanai T, Ichikawa W, Takagi Y, Uetake H, Nihei Z and Sugihara K: Expression of pyrimidine nucleoside phosphorylase (PyNPase) in colorectal cancer. Jpn J Clin Oncol 31: 500-505, 2001. (Pubitemid 33039765)
9. Hiroyasu S, Shiraishi M, Samura H, Tokashiki H, Shimoji H, Isa T and Muto Y: Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Jpn J Clin Oncol 31: 65-68, 2001. (Pubitemid 32293966)
10. Hata Y, Takahashi H, Sasaki F, Ogita M, Uchino J, Yoshimoto M, Akasaka Y, Nakanishi Y and Sawada Y: Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5′-deoxy-5- fluorouridine (5′DFUR) on breast cancer. Breast Cancer Res Treat 7: 37-41, 2000.
11. Mimori K, Ueo H, Shirasaka C, Shiraishi T, Yamagata M, Haraguchi M and Mori M: Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis. Ann Oncol 10: 111-113, 1999. (Pubitemid 29090600)
12. Yamagata M, Mori M, Mimori K, Mafune K-I, Tanaka Y, Ueo H and Akiyoshi T: Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesphageal cancer. Br J Cancer 79: 565-569, 1999. (Pubitemid 29046237)
13. Haba A, Monden T, Sekimoto M, Ikeda K, Izawa H, Kanou T, Amano M, Kan'yama H and Monden M: PyNPase expession in human colon cancer. Cancer Lett 122: 85-92, 1998. (Pubitemid 28058621)
14. Ishikawa T, Ura M, Yamamoto T, Tanaka Y and Ishitsuka H: Selective inhibition of spontaneous pulmonary metastasis of Lewis lung carcinoma by 5′-deoxy-5-fluorouridine. Int J Cancer 61: 516-521, 1995.
15. Nio Y, Kimura H, Tsubono M, Tseng C, Kawabata K, Masai Y, Hayashi H, Meyer C, Fukumoto M and Tobe T: Antitumor activity of 5′-deoxy-5- fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs. Anticancer Res 12: 1141-1146, 1992.
16. Haraguchi M, Furukawa T, Sumizawa T and Akiyama S: Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res 53: 5680-5682, 1993. (Pubitemid 23360271)
17. Ueda M, Ueki M, Terai Y, Morimoto A, Fujii H, Yoshizawa K and Yanagihara T: Stimulatory effects of EGF and TGF-alfa on invasive activity and 5′-deoxy-5-fluorouridine sensitivity in uterine cervical carcinoma SKGTIIb cells. Int J Cancer 72: 1027-1033, 1997. (Pubitemid 27433569)
18. Konno S, Takebayashi Y, Aiba M, Akiyama S and Ogawa K: Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. CacerLett 166: 103-111, 2001. (Pubitemid 32274291)
19. Kimura H, Konishi K, Nukui T, Kaji M, Maeda K, Yabushita K, Tsuji M and Miwa A: Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma. J Surg Oncol 76: 31-36, 2001. (Pubitemid 32128360)
20. Osaki M, Sakatani T, Okamoto E, Goto E, Adachi H and Ito H: Thymidine phosphorylase expression results in a decrease in apoptosis and increase in intratumoral microvessel density in human gastric carcinomas. Virchows Arch 437: 31-36, 2000. (Pubitemid 30446913)
21. Sakatani T, Okamoto E, Tsujitani S, Ikeguchi M, Kaibara N and Ito H: Expression of thymidine phosphorylase (dThdPase) and vascular endothelial growth factor on angiogenesis in intestinal-type gastric carcinoma. Oncol Rep 7: 831-836, 2000.
22. Kikuyama S, Inada T, Shimizu K and Miyakita M: Thymidine phosphorylase expression in gastric cancer in association with proliferative activity and angiogenesis. Anticancer Res 20: 2081-2086, 2000. (Pubitemid 30636187)
23. Shimaoka S, Matsushita S, Nitanda T, Matsuda A, Nioh T, Suenaga T, Nishimata Y, Akiba S, Akiyama S and Nishimata H: The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma. Cancer 88: 2220-2227, 2000. (Pubitemid 30247120)
24. Ikeguchi M, Oka S, Saito H, Kondo A, Tsujitani S, Maeta M and Kaibara N: The expression of thymidine phosphorylase and its correlation with angiogenesis in gastric adenocarcinoma. Anticancer Res 19: 4001-4006, 1999.
25. Ogawa K, Konno S, Takebayashi Y, Miura K, Katsube T, Kajiwara T, Aiba M, Aikou T and Akiyama S: Clinicopathological and prognostic significance of thymidine phosphorylase expression in gastric carcinoma. Anticancer Res 19: 4363-4368, 1999.
26. Saito H, Tsujitani S, Kondo A, Ikeguchi M, Maeta M and Kaibara N: The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma. Br J Cancer 81: 484-489, 1999. (Pubitemid 29458803)
27. Koizumi W, Saigenji K, Nakamaru N, Okayasu I and Kurihara M: Prediction of response to 5′-deoxy-5-fluorouridine(5′-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor. Oncology 56: 215-222, 1999. (Pubitemid 29161291)
28. Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Tsuburaya A, Nakamura Y, Shimizu A, Yanoma S and Noguchi Y: Thymidine phosphorylase/ platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer. Br J Cancer 79: 1145-1150, 1999. (Pubitemid 29087888)
29. Takahashi Y, Bucana CD, Akagi Y, Liu W, Cleary KR, Mai M and Ellis LM: Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res 4: 429-434, 1998. (Pubitemid 28122759)
30. Tanigawa N, Amaya H, Matsumura M, Katoh Y, Kitaoka A, Aotake T, Shimomatsuya T, Rosenwasser OA and Iki M: Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma. Cancer Lett 108: 281-290, 1996. (Pubitemid 26413534)
31. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y and Sowa M: Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884-888, 1996. (Pubitemid 26116738)
32. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T and Aikou T: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288-295, 1996. (Pubitemid 26117060)
33. Sobin LH and Wittekind CH: TNM Classification of Malignant Tumours. 6th edition. pp65-68, 2002.
34. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer 1: 10-24, 1998.
35. Ueda M, Kitaura K, Kusada O, Mochizuki Y, Yamada N, Terai Y, Kumagai K, Ueki K and Ueki M: Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells. Jpn J Cancer Res 91: 1185-1191, 2000.